A Phase 1 First-in-Human Study Evaluating AMG 900 in Advanced Solid Tumors

NCT00858377 · clinicaltrials.gov ↗
PHASE1
Phase
COMPLETED
Status
95
Enrollment
INDUSTRY
Sponsor class

Conditions

Interventions

Sponsor

Amgen